BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21507532)

  • 1. [Invasive meningococcal disease due to Neisseria meningitidis serogroup Y].
    Rentero Z; Romero-Gómez MP
    Enferm Infecc Microbiol Clin; 2011; 29(7):555-6. PubMed ID: 21507532
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine].
    Turhan V; Acar A; Kılıç A; Budak S; Oncül O; Haznedaroğlu T; Görenek L
    Mikrobiyol Bul; 2010 Jul; 44(3):473-8. PubMed ID: 21063998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual cause of acute polyarticular arthritis.
    Germino KW; Street MH; Caudill KA; Barenkamp SJ
    Clin Pediatr (Phila); 2009 Mar; 48(2):220-3. PubMed ID: 18832545
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal serotype Y myopericarditis.
    Nkosi J; Thakrar A; Kumar K; Ahmadie R; Fang T; Lytwyn M; Francis A; Kasper K; Kirkpatrick I; Jassal DS
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):223-7. PubMed ID: 19026509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections by Neisseria meningitidis serogroup X in Spain.
    del Castillo CM; Vázquez JA; Romero J; Pascual A
    Clin Microbiol Infect; 2003 Sep; 9(9):964-5. PubMed ID: 14616687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumonia due to Neisseria meningitidis serogroup Y].
    Pérez J; Gutiérrez A; Ezpeleta C; Cisterna R
    Enferm Infecc Microbiol Clin; 2003 May; 21(5):278. PubMed ID: 12732123
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region.
    Abad R; Agudelo CI; Brandileone MC; Chanto G; Gabastou JM; Hormazabal JC; O Gorla MC; Maldonado A; Moreno J; Muros-Le Rouzic E; Lersch R; Regueira M; Salcedo C; Sorhouet C; Vázquez JA
    J Infect; 2009 Aug; 59(2):104-14. PubMed ID: 19576638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab.
    Polat M; Yüksel S; Şahin NÜ
    Hum Vaccin Immunother; 2018; 14(11):2802. PubMed ID: 29883245
    [No Abstract]   [Full Text] [Related]  

  • 10. Invasive disease due to Neisseria meningitidis serogroup W.
    Román-Soto S; Sarría-Visa A; Pescador-Martín P
    Med Clin (Barc); 2018 Jun; 150(12):e41. PubMed ID: 29198582
    [No Abstract]   [Full Text] [Related]  

  • 11. Infection with Neisseria meningitidis serogroup Y revealing systemic lupus erythematosus.
    Zenone T; Sartre J; Gibert C; Gallen-Labbé F
    Lupus; 2010 Dec; 19(14):1676-8. PubMed ID: 20667940
    [No Abstract]   [Full Text] [Related]  

  • 12. Expanding prevention of invasive meningococcal disease.
    Pelton SI; Gilmet GP
    Expert Rev Vaccines; 2009 Jun; 8(6):717-27. PubMed ID: 19485753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.
    Pace D
    Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillin-resistant Neisseria meningitidis bacteraemia, Kimberley region, March 2010.
    Abeysuriya SD; Speers DJ; Gardiner J; Murray RJ
    Commun Dis Intell Q Rep; 2010 Sep; 34(3):342-4. PubMed ID: 21090191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New frontiers in meningococcal vaccines.
    Anderson AS; Jansen KU; Eiden J
    Expert Rev Vaccines; 2011 May; 10(5):617-34. PubMed ID: 21604983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 17. Serogroup Y meningococcal disease, Colombia.
    Inés Agudelo C; Sanabria OM; Ovalle MV
    Emerg Infect Dis; 2008 Jun; 14(6):990-1. PubMed ID: 18507927
    [No Abstract]   [Full Text] [Related]  

  • 18. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.
    Bröker M; Bukovski S; Culic D; Jacobsson S; Koliou M; Kuusi M; Simões MJ; Skoczynska A; Toropainen M; Taha MK; Tzanakaki G
    Hum Vaccin Immunother; 2014; 10(6):1725-8. PubMed ID: 24608912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological and genetic characterization of meningococcal isolates in Korea.
    Bae SM; Kang YH
    Jpn J Infect Dis; 2008 Nov; 61(6):434-7. PubMed ID: 19050348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.